MILAN/BRUSSELS (Reuters) – AstraZeneca will deliver 180 million COVID-19 vaccines to Europe in the second quarter, including 20 million to Italy, the head of its…
Home »
AstraZeneca expects U.S. COVID-19 vaccine authorization in April
FILE PHOTO: AstraZeneca’s logo is reflected in a drop on a syringe needle in this illustration taken November 9, 2020. REUTERS/Dado Ruvic/Illustration(Reuters) – AstraZeneca Plc…
AstraZeneca expects U.S. trial results in next 4-6 weeks, research chief says
FILE PHOTO: The AstraZeneca logo is pictured outside the AstraZeneca office building in Brussels as part of the coronavirus disease (COVID-19) vaccination campaign, Belgium, January…
Oxford finds COVID-19 shot 76% effective for 3 months after single dose
LONDON (Reuters) – Oxford University and AstraZeneca’s COVID-19 vaccine showed in a study it had 76% efficacy against symptomatic infection for three months after a…
CEO says AstraZeneca likely to run new global trial of COVID-19 vaccine: Bloomberg News
(Reuters) – AstraZeneca is likely to run an additional global trial to assess the efficacy of its COVID-19 vaccine using a lower dosage, its chief…
AstraZeneca should know by year-end whether vaccine works if trials restart
ZURICH/FRANKFURT (Reuters) – AstraZeneca’s should still know before the end of the year whether its experimental vaccine protects people against COVID-19, the drugmaker’s chief executive…
AstraZeneca pauses coronavirus vaccine trial as participant illness investigated
LONDON (Reuters) – AstraZeneca’s (AZN.L) suspension of global trials of its experimental coronavirus vaccine after an illness in a study subject in Britain has cast…
AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares
LONDON (Reuters) – AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares…
AstraZeneca pauses coronavirus vaccine trial, rollout doubts dent shares
LONDON (Reuters) – AstraZeneca has paused global trials of its experimental coronavirus vaccine after an unexplained illness in a participant, denting the British drugmaker’s shares…
AstraZeneca suspends leading COVID-19 vaccine trials after a participant's illness
(Reuters) – AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in…